Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
2200
Trial Sponsor
Clinical Trial Start Date
January 27, 2021
0Primary Completion Date
October 14, 2022
0Study Completion Date
October 14, 2022
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Prevention0
Intervention Type
Device0
Drug0
Intervention Name
INO-45000
CELLECTRA™ 20000
Placebo0
Interventional Trial Phase
Phase 10
Official Name
Dose-Ranging Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4500 in Combination With Electroporation in Healthy Volunteers in Ghana0
Last Updated
November 21, 2022
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Triple0
Masked Party
Participant0
Investigator0
Care Provider0
Study summary
This is a randomized, blinded, placebo-controlled trial to evaluate the safety, tolerability and immunological profile of INO-4500 administered by intradermal (ID) injection followed by electroporation (EP) using CELLECTRA™ 2000 device in healthy volunteers in Ghana.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
